GENE ONLINE|News &
Opinion
Blog

Antisense Oligonucleotides
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
AstraZeneca, Ionis Close $3.5+ Billion Deal for Rare Protein Misfolding Disorder
2021-12-30
Wave Initiates Trial of Investigational Antisense Oligonucleotide Against Huntington’s Disease
2021-09-13
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
Part II Highlights of BIO Asia-Taiwan 2020 (Day 1): Global Trends in Biotech and the Impact of COVID-19
2020-07-23Partner
Spotlight: Roche’s SMA Drug, Risdiplam Makes Strong Case for Regulatory Approval
2020-07-05
Biogen’s SMA Drug, Spinraza Continues to Show Benefits in Pre-Symptomatic Patients
2020-06-14
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
North Star Review Board Launches Nonprofit Model for Institutional Oversight
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
106 Adults Receive Free Dementia Screenings at Atlanta Community Organizations
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
Boston College Chemist Receives $600,000 NSF Grant to Study Transition Metal Oxychlorides for Battery Storage
2026-08-10
Researchers Identify Related Viruses to Mitigate Koi Herpesvirus in Carp Populations
2026-08-10
Scroll to Top